Blood test validation for multiple cancer types
Part of Cancer clinical trials.
This study collects blood samples from people being treated for certain cancers to check if a new blood test (TST79) can help detect or monitor cancer. If you have one of the listed cancer types and are currently receiving treatment, you may be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these cancers: lung, colorectal, breast, prostate, kidney, stomach/intestinal stromal tumor, melanoma, bladder, endometrial, or ovarian cancer
- You are currently receiving cancer treatment (such as chemotherapy, immunotherapy, or targeted therapy)
- You are willing to give a blood sample for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study uses blood samples to look for tiny pieces of cancer cells called circulating tumor cells. Your results may help researchers understand how cancer cells spread and how cancer could be monitored over time.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.